Bruce Montgomery

Bruce Montgomery biotech startup Cardeas Pharma raises $34 million

It has been a good week for the Seattle life sciences community. On Monday, Seattle genomics tool maker NanoString Technologies filed for an initial public offering that could raise up to $86 million. Now, comes word that Cardeas Pharma Corporation, a biopharmaceutical company led by Seattle biotech veteran Bruce Montgomery, has raised $34 million in funding…. Read More


Report: Cardeas Pharma raises $5M

Cardeas Pharma, a biotechnology company led by Seattle biotech entrepreneur Bruce Montgomery, has reeled in $5 million in venture financing from Novo Ventures, Avalon Ventures, WRF Capital and others, reports Xconomy. The round is expected to close with up to $7.5 million. Montgomery is a well regarded biotech leader, having previously sold Corus Pharma to Gilead Sciences… Read More